Beyond analysts' top-and-bottom-line estimates for C.H. Robinson (CHRW), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for SEI (SEIC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.

As gold prices surged past $5,000 an ounce in early 2026, major banks raise their upside forecasts as they reassessed the scale and sustainability of the rally for the safe haven metal. Deutsche Bank now sees gold reaching $6,000/oz, driven by rising investment demand and a fundamental shift in the geopolitical and macroeconomic backdrop.

Evaluate the expected performance of Textron (TXT) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Evaluate the expected performance of Dover (DOV) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Besides Wall Street's top-and-bottom-line estimates for Rogers Communication (RCI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Get a deeper insight into the potential performance of Cullen/Frost (CFR) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Besides Wall Street's top-and-bottom-line estimates for Norfolk Southern (NSC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Beyond analysts' top-and-bottom-line estimates for Carpenter (CRS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

Get a deeper insight into the potential performance of Oshkosh (OSK) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Get a deeper insight into the potential performance of A.O. Smith (AOS) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Q1. Is there oil and gas in Greenland? Yes. The best potential for oil and gas is offshore of eastern Greenland.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Klarna To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Klarna pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Klarna's September 2025 initial public offering (the "IPO")and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 27, 2026) - Faruqi & …

FedRAMP milestone underscores long-standing trust, leadership, and commitment to rigorous federal security standards WASHINGTON, Jan. 27, 2026 /PRNewswire/ -- LexisNexis® Risk Solutions, a leading provider in data, analytics, and mission-critical government technology solutions, today announced that the company has achieved FedRAMP® "In Process" status, with sponsorship from the U.S. General Services Administration (GSA). This milestone marks significant progress toward full FedRAMP Authorization and reinforces the company's commitment to delivering secure, compliant, and resilient cloud solutions that support federal missions nationwide.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered significant losses in Aquestive Therapeutics stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 27, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") …

WDC sees fiscal Q2 2026 non-GAAP revenue of $2.9B, up 20% year over year, as data center demand and high-capacity drives support growth momentum.

Paccar (PCAR) came out with quarterly earnings of $1.06 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.66 per share a year ago.

LOS ANGELES, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Varonis Systems, Inc. (“Varonis” or “the Company”) (NASDAQ: VRNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 4, 2025 and October 28, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before March 9, 2026.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 27, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. ("Ardent" …